Share This Article:

Disease prevention without relapse: Processes of change for HPV vaccination

Full-Text HTML Download Download as PDF (Size:432KB) PP. 301-309
DOI: 10.4236/ojpm.2013.33041    3,522 Downloads   5,155 Views   Citations

ABSTRACT

Background: Human papillomavirus is the most prevalent sexually transmitted infection in the United States and is associated with 70% of cervical cancers as well as over 90% of genital warts. Although the HPV vaccine appears in the US immunization schedule during adolescence, a large percentage of women reach adulthood without being vaccinated. The Transtheoretical Model’s (TTM) Processes of Change (POC) construct provides an assessment of participants’ experiences with HPV vaccination and is a central component of computer-tailored interventions designed to increase compliance with medical recommendations, such as vaccination. This study describes development and validation of a POC measure for increasing HPV vaccination among young adult women. Methods: Cross-sectional measurement development was conducted using an online survey to reach a sample of 340 female college students representing vaccinated and unvaccinated women. Factor analytic structural equation modeling as well as evaluations of the stage by POC were used to evaluate the validity of the POC measure. Results: Confirmatory analyses supported the theoretically expected ten-factor, fully correlated model as the best fit for the data. Expected Stage of Change to POC relationships were also confirmed insofar as each POC was significantly associated with Stage of Change, with the exception of dramatic relief. Follow-up analyses suggested that individuals in the Precontemplation stage used all POC less frequently than individuals in all other stages. Conclusions: The POC measure was found to be internally and externally valid in a sample of college-attending women. The POC measure developed may be used to tailor stage-matched interventions that increase use of experiential and behavioral strategies important for increasing HPV vaccination in this high-risk population.

Cite this paper

Fernandez, A. , Paiva, A. , Lipschitz, J. , Larson, H. , Amoyal, N. , Blaney, C. , Sillice, M. , Redding, C. and Prochaska, J. (2013) Disease prevention without relapse: Processes of change for HPV vaccination. Open Journal of Preventive Medicine, 3, 301-309. doi: 10.4236/ojpm.2013.33041.

References

[1] Centers for Disease Control and Prevention (2008) Genital HPV infection—Fact sheet. http://www.cdc.gov/std/hpv/stdfact-hpv.htm
[2] Koutsky, L. (1997) Epidemiology of genital human papillomavirus infection. The American Journal of Medicine, 102, 3-8. doi:10.1016/S0002-9343(97)00177-0
[3] Myers, E.R., McCrory, D.C., Nanda, K., Bastian, L. and Matchar, D.B. (2000) Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. American Journal of Epidemiology, 151, 1158-1171. doi:10.1093/oxfordjournals.aje.a010166
[4] Baseman, J.G. and Koutsky, L.A. (2005) The epidemiology of human papillomavirus infections. Journal of Clinical Virology, 32S, S16-S24. doi:10.1016/j.jcv.2004.12.008
[5] Dunne, E.F., Unger, E.R., Sternberg, M., McQuillan, G., Swan, D.C., Patel, S.S., et al. (2007) Prevalence of HPV infection among females in the United States. Journal of the American Medical Association, 297, 813-819. doi:10.1001/jama.297.8.813
[6] Trottier, H. and Franco, E.L. (2006) The epidemiology of genital human papillomavirus infection. Vaccine, 24, 4-15. doi:10.1016/j.vaccine.2005.09.054
[7] Winer, R.L., Hughes, J.P., Feng, Q., O’Reilly, S., Kiviat, N.B., Holmes, K.K., et al. (2006) Condom use and the risk of genital human papillomavirus infection in young women. The New England Journal of Medicine, 354, 2645-2654. doi:10.1056/NEJMoa053284
[8] Ho, G.Y., Bierman, R., Beardsley, L., Chang, C.J. and Burk, R.D. (1998) Natural history of cervicovaginal papillomavirus infection in young women. The New England Journal of Medicine, 338, 423-428. doi:10.1056/NEJM199802123380703
[9] The Future II Study Group (2007) Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. The New England Journal of Medicine, 356, 1915-1927. doi:10.1056/NEJMoa061741
[10] Markowitz, L.E., Dunne, E.F., Saraiya, M., Lawson, H.W., Chesson, H. and Unger, E.R. (2007) Quadrivalent human papillomavirus vaccine: Recommendations of the advisorty committee on iimmunization practices (ACIP). Morbidity and Mortality Weekly Report, 56, 1-24. doi:10.1016/j.vaccine.2008.01.013
[11] Harper, D.M. and Paavonen, J. (2008) Age for HPV vaccination. Vaccine, 26, A7-A18.
[12] Dorrell, C., Stokley, S., Yankey, D., Cohn, A. and Markowitz, L. (2010) National, state, and local area vaccination coverage among adolescents aged 13-17 years—United States, 2009. Morbidity and Mortality Weekly Report, 59, 1018-1023.
[13] Greby, S., Lu, P., Euler, G., Williams, W.W. and Singleton, J.A. (2009) Adult vaccination coverage. http://www.cdc.gov/vaccines/stats-surv/nhis/2009-nhis.htm
[14] Hall, K.L. and Rossi, J.S. (2008) Meta-analytic examination of the strong and weak principles across 48 health behaviors. Preventive Medicine, 46, 266-274. doi:10.1016/j.ypmed.2007.11.006
[15] DiClemente, C.C., Prochaska, J.O., Fairhurst, S.K., Velicer, W.F., Velasquez, M.M. and Rossi, J.S. (1991) The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change. Journal of Consulting and Clinical Psychology, 59, 295304. doi:10.1037/0022-006X.59.2.295
[16] Prochaska, J.O. and DiClemente, C.C. (1983) Stages and processes of self-change of smoking: Toward integrative model of change. Journal of Consulting and Clinical Psychology, 51, 390-395. doi:10.1037/0022-006X.51.3.390
[17] Velicer, W.F., DiClemente, C.C., Prochaska, J.O. and Brandenburg, N. (1985) Decisional balance measure for assessing and predicting smoking status. Journal of Personality and Social Psychology, 48, 1279-1289. doi:10.1037/0022-3514.48.5.1279
[18] Bandura, A. (1977) Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84, 191215. doi:10.1037/0033-295X.84.2.191
[19] DiClemente, C.C., Prochaska, J.O. and Gibertini, M. (1985) Self-efficacy and the stages of self-change of smoking. Cognitive Therapy and Research, 9, 181-200. doi:10.1007/BF01204849
[20] Velicer, W.F., Diclemente, C.C., Rossi, J.S. and Prochaska, J.O. (1990) Relapse situation and self-efficacy: An integrative model. Addictive Behaviors, 15, 271-283. doi:10.1016/0306-4603(90)90070-E
[21] DiClemente, C.C. and Prochaska, J.O. (1985) Processes and stages of self-change: Coping and competence in smoking behavior change. In: Shiffman, S. and Willis, T.A., Eds., Coping and Substance Use. Academic Press, New York, 319-343.
[22] Prochaska, J.O., Velicer, W.F., DiClemente, C.C. and Fava, J. (1988) Measuring processes of change: Applications to the cessation of smoking. Journal of Consulting and Clinical Psychology, 56, 520-528. doi:10.1037/0022-006X.56.4.520
[23] Rosen, C.S. (2000) Is the sequencing of change processes by stage consistent across health problems? A meta-analysis. Health Psychology, 19, 593-604. doi:10.1037/0278-6133.19.6.593
[24] Hall, K.L., Robbins, M.L., Paiva, A., Knott, J.E., Harris, L. and Mattice, B. (2007) Donation intentions among African American college students: Decisional balance and self-efficacy measures. Journal of Behavioral Medicine, 30, 483-495. doi:10.1007/s10865-007-9121-8
[25] Robbins, M.L., Levesque, D.A., Redding, C.A., Johnson, J.L., Prochaska, J.O., Rohr, M.S., et al. (2001) Assessing family members’ motivational readiness and decision making for consenting to cadaveric organ donation. Journal of Health Psychology, 6, 523-535. doi:10.1177/135910530100600506
[26] Jackson, D.N. (1970) A sequential approach for personality scale development. Academic Press, New York.
[27] Jackson, D.N. (1971) The dynamics of structured personality tests. Psychological Review, 78, 229-248. doi:10.1037/h0030852
[28] Noar, S.M. (2003) The role of structural equation modeling in scale development. Structural Equation Modeling, 10, 622-647. doi:10.1207/S15328007SEM1004_8
[29] Nigg, C.R., Norman, G.H., Rossi, J.S. and Benisovich, S.V. (1999) Processes of exercise behavior change: Redeveloping the scale. Annals of Behaivoral Medicine, 21, S79.
[30] Freyer, J., Bott, K., Riedel, J., Wedler, B., Meyer, C., Rumpf, H.J., et al. (2006) Psychometric properties of the “processes of change” scale for alcohol misuse and its short form (POC-20). Addictive Behaviors, 31, 821-832. doi:10.1016/j.addbeh.2005.06.007
[31] Amoyal, N.R., Robbins, M.L., Paiva, A.L., Burditt, C., Kessler, D. and Shaz, B.H. (2012) Measuring the processes of change for increasing blood donation in black adults. Transfusion, in Press. doi:10.1111/j.1537-2995.2012.03864.x
[32] Larson, H.E., Blaney, C., Kobayashi, H., Sillice, M., Fernandez, A., Lipschitz, J., et al. (2011) HPV knowledge and stages of change measure for HPV vaccing completion among college women. Society of Behavioral Medicine, Washington DC.
[33] Cohen, J. (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum, New Jersey.
[34] Anatchkova, M.D., Velicer, W.F. and Prochaska, J.O. (2005) Replication of subtypes for smoking cessation within the contemplation stage of change. Addictive Behaviors, 30, 915-927. doi:10.1016/j.addbeh.2005.08.002
[35] Velicer, W.F., Prochaska, J.O., Bellis, J.M., DiClemente, C.C., Rossi, J.S., Fava, J.L., et al. (1993) An expert system intervention for smoking cessation. Addictive Behaviors, 18, 269-290. doi:10.1016/S0738-3991(98)00129-3
[36] Lipschitz, J.M., Fernandez, A.C., Larson, H.E., Blaney, C.L., Meier, K.S., Redding, C.A., Prochaska, J.O. and Paiva, A.L. (2013) Validation of decisional balance and self-efficacy measures for HPV vaccination in college women. American Journal of Health Promotion, in Press.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.